American states have used different approaches in adoption of cannabis policies and continue to modify those policies after approval. States also differ in how long it takes to implement such policies, and this influences the availability of legal marijuana. Such policy differences and implementation timelines could influence usage of marijuana and other illicit drugs by adolescents, young adults, and older adults. We develop an original coding scheme for marijuana legalization policies by classifying policy bundles characterized by three views of marijuana: as a pharmaceutical; as a permissive drug, or as a state fiscal revenue source. We test the impact of state legal marijuana policy characteristics on age group rates of marijuana use with panel regression models including control variables and fixed effects for 2000–2019. This design moves beyond a dichotomous construct of marijuana legalization and accounts for the dynamic adaptation of policies beyond their initial adoption. States with a higher pharmaceutical score experienced lower marijuana usage rates for adolescents and young adults while states with a permissive approach or fiscal approach experienced higher rates of marijuana use for all age groups. We find no consistent spillover effect of the pharmaceutical or permissive marijuana policy bundles on other illicit drug use for any age group, but fiscal bundles show some association with greater illicit drug use for adults. These more nuanced measures better reflect state policies as implemented and provide more clarity of the policy impact on target populations’ marijuana usage.
BachhuberM. A.SalonerB.CunninghamC. O.BarryC. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med, 174(10), 1668–1673. https://doi.org/10.1001/jamainternmed.2014.4005
2.
BachmanJ. G.JohnsonL. D.O'MalleyP. M. (1998). Explaining recent increases in students’ marijuana use: impacts of perceived risks and disapproval, 1976 through 1996. Am J Public Health, 88(6), 887–892. https://doi.org/10.2105/ajph.88.6.887
3.
BraakmannN.JonesS. (2014). Cannabis depenalisation, drug consumption and crime–Evidence from the 2004 cannabis declassification in the UK. Social Science & Medicine, 115(1), 29–37. https://doi.org/10.1016/j.socscimed.2014.06.003
4.
BoehmkeF. J. (2009). Approaches to modeling the adoption and diffusion of policies with multiple components. State Politics & Policy Quarterly, 9(2), 229–252. https://doi.org/10.1177/153244000900900205
5.
BoehmkeF. J.WitmerR. (2004). Disentangling diffusion: The effects of social learning and economic competition on state policy innovation and expansion. Political Research Quarterly, 57(1), 39–51. https://doi.org/10.2307/3219833
6.
BradfordA. C.BradfordW. D.AbrahamA.Bagwell AdamsG. (2018). Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Intern Med, 178(5), 667–672. https://doi.org/10.1001/jamainternmed.2018.0266
7.
BradfordA. C.BradfordW. D. (2016). Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Aff, 35(1), 1230–1236. https://doi.org/10.1377/hlthaff.2015.1661
8.
CarleyS.MillerC. J. (2012). Regulatory stringency and policy drivers: A reassessment of renewable portfolio standards. Policy Studies Journal, 40(4), 730–756. https://doi.org/10.1111/j.1541-0072.2012.00471.x
9.
CerdáM.SarvetA. L.WallM.FengT.KeyesK. M.GaleaS.HasinD. S. (2018). Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs. Drug and Alcohol Dependence, 183(1), 62–68. https://doi.org/10.1016/j.drugalcdep.2017.10.021
10.
ChapmanS. A.SpetzJ.LinJ.ChanK.SchmidtL. A. (2016). Capturing heterogenity in medical marijuana policies: A taxonomy of regulatory regimes across the United States. Substance Use & Misuse, 51(1), 1174–1184. https://doi.org/10.3109/10826084.2016.1160932
11.
ChooE. K.BenzM.ZallerN.WarrenO.RisingK. L.McConnellK. J. (2014). The impact of state medical marijuana legislation on adolescent marijuana use. J Adolesc Health, 55(2), 160–166. https://doi.org/10.1016/j.jadohealth.2014.02.018
12.
ColeyR. L.KruzikC.GhianiM.CareyN.HawkinsS. S.BaumC. F. (2020). Recreational marijuana legalization and adolescent use of marijuana, tobacco, and alcohol. Journal of Adolescent Health, 69(1), 1–9. https://doi.org/10.1016/j.jadohealth.2020.10.019
13.
CunninghamS. (2021). Causal Inference: The Mixtape. Yale University Press.
14.
DragoneD.PraroloG.VaninP.ZanellaG. (2019). Crime and the legalization of recreational marijuana. J Econ Behav Organ, 159(C), 488–501. https://doi.org/10.1016/j.jebo.2018.02.005
15.
EdwardsJ. H.EdwardsA. W. F. (1983). Approximating the tetrachoric correlation coefficient. Biometrics, 39(1), 753–757.
16.
FiskJ. M.VonasekJ. A.DavisE. (2018). “Pot”reneurial politics: the budgetary highs and lows of recreational marijuana policy innovation. Polit Policy, 46(2), 189–208. https://doi.org/10.1111/polp.12246
17.
GhimireK. M.MacleanJ. C. (2020). Medical marijuana and workers' compensation claiming. Health Economics, 29(1), 419–434. https://doi.org/10.1002/hec.3992
18.
GlazierR. E.KlingR. N. (2013). Recent trends in substance abuse among persons with disabilities compared to that of persons without disabilities. Disabil Health J, 6(2), 107–115. https://doi.org/10.1016/j.dhjo.2013.01.007
19.
GuttmannovaK.JonesA. A.JohnsonJ. K.OesterleS.JohnsonR. M.MartinsS. S. (2019). Using existing data to advance knowledge about adolescent and emerging adult marijuana use in the context of changes in marijuana policies. Prev Sci, 20(2), 291–299. https://doi.org/10.1007/s11121-019-00991-w
20.
HaoZ.CowanB. W. (2020). The cross-border spillover effects of recreational marijuana legalization. Econ Inq, 58(2), 642–666. https://doi.org/10.1111/ecin.12764
21.
HannahA. L.MallinsonD. J. (2017). Defiant innovation: The adoption of medical marijuana laws in the American states. Policy Studies Journal, 46(2), 402–423. https://doi.org/10.1111/psj.12211
22.
HarperS.StrumpfE. C.KaufmanJ. S. (2012). Do medical marijuana laws increase marijuana use? Replication study and extension. Ann Epidemiol, 22(3), 207–212. https://doi.org/10.1016/j.annepidem.2011.12.002
23.
HasinD. S.ShmulewitzD.SarvetA. L. (2019). Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: A narrative review and new findings. Am J Drug Alcohol Abuse, 45(6), 623–643. https://doi.org/10.1080/00952990.2019.1569668
24.
HathawayA. D.ComeauN. C.EricksonP. G. (2011). Cannabis normalization and stigma: contemporary practices of moral regulation. Criminology and Criminal Justice, 11(5), 451–469. https://doi.org/10.1177/1748895811415345
25.
HayesM. J.BrownM. S. (2014). Legalization of medical marijuana and incidence of opioid mortality. JAMA Internal Medicine, 174(10), 1673–16734. https://doi.org/10.1001/jamainternmed.2014.2716
26.
HuberA.IIINewmanR.LaFaveD. (2016). Cannabis control and crime: Medicinal use, depenalization and the war on drugs. BE Journal of Economic Analysis & Policy, 16(4), 1–35. https://doi.org/10.1515/bejeap-2015-0167
27.
JohnsonJ.HodgkinD.HarrisS. K. (2017). The design of medical marijuana laws and adolescent use and heavy use of marijuana: Analysis of 45 states from 1991 to 2011. Drug Alcohol Depend, 170(1), 1–8. https://doi.org/10.1016/j.drugalcdep.2016.10.028
28.
KeyesK. M.WallM.CerdáM.SchulenbergJ.O'malleyP. M.GaleaS.FengT.HasinD. S. (2016). How does state marijuana policy affect US youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991–2014. Addiction, 111(12), 2187–2195. https://doi.org/10.1111/add.13523
29.
Lynne-LandsmanS. D.LivingstonM. D.WagenaarA. C. (2013). Effects of state medical marijuana laws on adolescent marijuana use. Am J Public Health, 103(8), 1500–1506. https://doi.org/10.2105/AJPH.2012.301117
30.
McGintyE. E.SamplesH.BandaraS. N.SalonerB.BachhuberM. A.BarryC. L. (2016). The emerging public discourse on state legalization of marijuana for recreational use in the US: analysis of news media coverage, 2010–2014. Prev Med, 90(1), 114–20. https://doi.org/10.1016/j.ypmed.2016.06.040
31.
MartinsS. S.MauroC. M.Santaella-TenorioJ.KimJ. H.CerdaM.KeyesK. M.HasinD. S.GaleaS.WallM. (2016). State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general US population. Drug and Alcohol Dependence, 169(1), 26–32. https://doi.org/10.1016/j.drugalcdep.2016.10.004
32.
MartinsS. S.SeguraL. E.LevyN. S.MauroP. M.MauroC. M.PhilbinM. M.HasinD. S. (2021). Racial and ethnic differences in cannabis use following legalization in US states with medical cannabis laws. JAMA Network Open, 4(9), Article e2127002. https://doi.org/10.1001/jamanetworkopen.2021.27002
33.
MaguraS (2010). Validating self-reports of illegal drug use to evaluate National Drug Control Policy: A reanalysis and critique. Eval Plann, 33(3), 234–237. https://doi.org/10.1016/j.evalprogplan.2009.08.004
34.
Mark AndersonD.HansenB.ReesD. I. (2013). Medical marijuana laws, traffic fatalities, and alcohol consumption. J Law Eco, 56(2), 333–369. https://doi.org/10.1086/668812
35.
Mark AndersonD.HansenB.ReesD. I. (2015). Medical marijuana laws and teen marijuana use. Am Law Econ Re, 17(2), 495–528. https://doi.org/10.1093/aler/ahv002
36.
MauroC. M.NewswangerP.Santaella-TenorioJ.MauroP. M.CarlinerH.MartinsS. S. (2019). Impact of medical marijuana laws on state-level marijuana use by age and gender, 2004–2013. Prev Sci, 20(2), 205–214. https://doi.org/10.1007/s11121-017-0848-3
37.
O’KeefeK. (2013). State medical marijuana implementation and federal policy. J of Health Care, Law and Policy, 16(1), 39–58.
38.
PaculaR. L.ChriquiJ. F.KingJ. (2003). Marijuana Decriminalization: What does it mean in the United States? (No. w9690). National Bureau of Economic Research.
39.
PaculaR. L.JacobsonM.MaksabedianE. J. (2016). In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction, 111(6), 973–80. https://doi.org/10.1111/add.13282
40.
PaculaR. L.MacCounR.ReuterP.ChriquiJ.KilmerB.HarrisK.PaoliL.SchäferC. (2005). What does it mean to decriminalize marijuana? A cross-national empirical examination. Emerald Group Publishing Limited.
41.
PaculaR. L.PowellD.HeatonP.SevignyE. L. (2015). Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J Policy Anal Manag, 34(1), 7–31. https://doi.org/10.1002/pam.21804
42.
PaculaR. L.KilmerB.GrossmanM.ChaloupkaF. J. (2010). Risks and prices: The role of user sanctions in marijuana markets. The BE Journal of Economic Analysis & Policy, 10(1), art11. https://doi.org/10.2202/1935-1682.1992
43.
PowellD.PaculaR. L.JacobsonM. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers?J Health Econ, 58(1) 29–42. https://doi.org/10.1016/j.jhealeco.2017.12.007
44.
Substance Abuse and Mental Health Services Administration (2010). Reliability of key measures in the national survey on drug use and health. In: Office of Applied Studies, Methodology Series M-8. HHS Publication No. SMA. 09-4425).
45.
Santaella-TenorioJ.Wheeler-MartinK.DiMaggioC. J.Castillo-CarnigliaA.KeyesK. M.HasinD.CerdáM. (2020). Association of recreational cannabis laws in Colorado and Washington state with changes in traffic fatalities, 2005-2017. JAMA Intern Med, 180(8), 1061–1068. https://doi.org/10.1001/jamainternmed.2020.1757
46.
SarvetA. L.WallM. M.FinkD. S.GreeneE.LeA.BousteadA. E.PaculaR. L.KeyesK. M.CerdáM.GaleaS.HasinD. S. (2018). Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis. Addiction, 113(6), 1003–1016. https://doi.org/10.1111/add.14136
47.
ShoverC. L.DavisC. S.GordonS. C.HumphreysK. (2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci U S A, 116(26), 12624–12626. https://doi.org/10.1073/pnas.1903434116
48.
U.S. Department of Health and Human Services. Substance abuse and mental health services administration, center for behavioral health statistics and quality. National survey on drug use and health: Small area estimation dataset: State small area estimates, by survey year, outcome, state, and age group. (2020). http://www.datafiles.samhsa.gov/study-series/national-survey-drug-use-and-health-nsduh-nid13517(Accessed 25 June 2020).
49.
WangG. S.DaviesS. D.HalmoL. S.SassA.MistryR. D. (2018). Impact of marijuana legalization in Colorado on adolescent emergency and urgent care visits. J Adolesc Health, 63(2), 239–241. https://doi.org/10.1016/j.jadohealth.2017.12.010
50.
WenH.HockenberryJ. M.CummingsJ. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ, 42(1), 64–80. https://doi.org/10.1016/j.jhealeco.2015.03.007
51.
WilkinsonS. T.YarnellS.RadhakrishnanR.BallS. A.D'SouzaD. C. (2016). Marijuana legalization: impact on physicians and public health. Annu Rev Med, 67(1), 453–66. https://doi.org/10.1146/annurev-med-050214-013454
52.
WilliamsA. R.OlfsonM.KimJ. H.MartinsS. S.KleberH. D. (2016). Older, less regulated medical marijuana programs have much greater enrollment rates than newer ‘medicalized’ programs. Health Affairs, 35(3), 480–8. https://doi.org/10.1377/hlthaff.2015.0528
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
